Segment & Geographic Data
Quant-Grade Normalized Data
API & CSV Delivery
Miragen Therapeutics Inc's Business Segments
Miragen Therapeutics Inc's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Segment Data As of Q3 FY2026
Reportable Segments
1
Largest Segment
Reportable
Total Revenue
$ 26
Regions Reported
-
API endpoints for this dataset
https://api.csimarket.com/api/v1/companies/MGEN/segments
https://api.csimarket.com/api/v1/companies/MGEN/geographic
https://api.csimarket.com/api/v1/companies/MGEN/exposure
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Connect Your AI Assistant
Revenue Share by Reportable Segment - Q3 FY2026
- Reportable100%
Revenue by Reportable Segment - Q3 FY2026
| Segment | Revenue (Millions) | % of Total |
|---|---|---|
| Reportable | $ 26 | 100% |
Revenue by Product & Service Category - Q3 FY2026
- Product95.8%
- Collaboration3.7%
- License0.5%
Revenue by Product & Service Category - Q3 FY2026
| Category | Revenue (Millions) | % of Total |
|---|---|---|
| Product | $ 25 | 95.8% |
| Collaboration | $ 1 | 3.7% |
| License | $ 0 | 0.5% |
Product and service categories are a supplemental disclosure and are not required to sum to consolidated revenue or to the reportable segments above.